Clinical Trial

Complex Treatment of a Chronic Anal Fissure

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 27, 2022 (before its estimated September 1, 2022 completion). Its status may not reflect the trial's current state.
Summary
This study is aimed at studying the efficacy and safety of treating chronic anal fissure with botulinum toxin versus lateral subcutaneous sphincterotomy.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2019-02-25; most recent amendment 2022-04-07.
Status change: Recruiting → Completed 2022-04-07
Trial Details
NCT Number NCT03855046
Lead Sponsor State Scientific Centre of Coloproctology, Russian Federation
Collaborators: St. Petersburg State Pavlov Medical University, Astrakhan State Medical University, Siberian State Medical University, City Clinical Hospital №24, Department of Health City of Moscow, GBUZ MO "Lvovskaia Raionaia Bolnica", Medical Center ON-CLINIC
Conditions Fissure in Ano
Enrollment 340 participants
Start Date 2019-09-01
Primary Completion 2022-09-01 (estimated)
Study Completion 2022-11-01 (estimated)
Updated on ClinicalTrials.gov 2022-01-27